Literature DB >> 9790929

Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.

Y Mori1, H Kim-Motoyama, T Katakura, K Yasuda, H Kadowaki, B A Beamer, A R Shuldiner, Y Akanuma, Y Yazaki, T Kadowaki.   

Abstract

To examine the role of the Pro12Ala variant of the human PPARgamma2 gene on adiposity and insulin resistance, we studied the effect of the variant on fat distribution assessed by CT scan, plasma glucose, and insulin levels during a 75g oral glucose load in 215 non-diabetic Japanese men. The allele frequency of the variant was 0. 03 in this population. There were no differences in body mass index (BMI), subcutaneous fat area (S), visceral fat area (V), V/S ratio, fasting plasma insulin levels, or insulin resistance index in homeostatic model assessment between 203 subjects who were homozygous for the wild-type Pro12 allele and 12 subjects with the variant Ala12 allele (11 heterozygotes and one homozygote). These data suggest that the Pro12Ala variant is not a major contributor to adiposity, fat distribution, or insulin resistance in Japanese men. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790929     DOI: 10.1006/bbrc.1998.9421

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene.

Authors:  A Marti; M S Corbalán; M A Martínez-González; L Forga; J A Martínez
Journal:  J Physiol Biochem       Date:  2002-12       Impact factor: 4.158

3.  Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.

Authors:  S Sauder; H Kölsch; D Lütjohann; A Schulz; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

4.  Is the Ala12 variant of the PPARG gene an "unthrifty allele"?

Authors:  E Ruiz-Narváez
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

5.  Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.

Authors:  Mary Helen Black; Jun Wu; Miwa Takayanagi; Nan Wang; Kent D Taylor; Talin Haritunians; Enrique Trigo; Jean M Lawrence; Richard M Watanabe; Thomas A Buchanan; Anny H Xiang
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

6.  Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study.

Authors:  Qi Wei; David R Jacobs; Pamela J Schreiner; David S Siscovick; Michael W Steffes; Myriam Fornage
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

7.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

Review 8.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease.

Authors:  Jean Dallongeville; Carlos Iribarren; Jean Ferrières; Liisa Lyon; Alun Evans; Alan S Go; Dominique Arveiler; Stephen P Fortmann; Pierre Ducimetière; Mark A Hlatky; Philippe Amouyel; Audrey Southwick; Thomas Quertermous; Aline Meirhaeghe
Journal:  PPAR Res       Date:  2009-12-01       Impact factor: 4.964

10.  The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study.

Authors:  Nancy A West; Mary N Haan; Hal Morgenstern
Journal:  Neurobiol Aging       Date:  2008-07-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.